KBL MERGER CORP. IV | Business Contracts

Separation and Release Agreement, dated January 18, 2023, by and between 180 Life Sciences Corp. and Quan Vu (Filed With SEC on January 20, 2023)

Amendment to the Warrant Agent Agreement, dated January 13, 2023, by and between 180 Life Sciences Corp. and the Warrant Agent (Filed With SEC on January 18, 2023)

Placement Agent Agreement, dated December 20, 2022, between 180 Life Sciences Corp. and A.G.P./Alliance Global Partners (Filed With SEC on December 22, 2022)

Settlement and Mutual Release Agreement dated September 17, 2021, by and between 180 Life Sciences Corp. and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C (Filed With SEC on September 20, 2021)

Form of August 21, 2019 Employment Agreement between KBL Merger Corp. IV and Jonathan Rothbard (Filed With SEC on July 9, 2021)

Warrant Amendment, dated January 12, 2023, by and between 180 Life Sciences Corp. and the Purchaser (Filed With SEC on January 12, 2023)

Third Amendment to Consulting Agreement dated December 28, 2022, between 180 Life Sciences Corp., Cannbiorex Pharma Ltd. and Prof. Jagdeep Nanchahal (Filed With SEC on December 29, 2022)

Securities Purchase Agreement, dated December 20, 2022, by and between 180 Life Sciences Corp. and the Purchaser (Filed With SEC on December 22, 2022)

Form of Pre-Funded Warrant (Filed With SEC on December 22, 2022)

Form of Common Warrant (Filed With SEC on December 22, 2022)

Warrant Agent Agreement for the Pre-Funded Warrants, dated December 22, 2022, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on December 22, 2022)

Warrant Agent Agreement for the Common Warrants, dated December 22, 2022, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company (Filed With SEC on December 22, 2022)

Form of Lock-Up Agreement (Filed With SEC on December 22, 2022)

Form of Lock-Up Agreement (Filed With SEC on July 19, 2022)

Securities Purchase Agreement dated July 17, 2022, by and between 180 Life Sciences Corp. and the Purchaser (Filed With SEC on July 19, 2022)

Form of Common Warrant (Filed With SEC on July 19, 2022)

Form of Pre-Funded Warrant (Filed With SEC on July 19, 2022)

Placement Agent Agreement dated July 17, 2022, between 180 Life Sciences Corp. and A.G.P./Alliance Global Partners (Filed With SEC on July 19, 2022)

180 Life Sciences Corp. 2022 Omnibus Incentive Plan (Filed With SEC on June 14, 2022)

Second Amendment to Employment Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and Quan Anh Vu (Filed With SEC on May 27, 2022)

Second Amendment to Employment Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D (Filed With SEC on May 27, 2022)

Second Amendment to Employment Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D (Filed With SEC on May 27, 2022)

Second Amendment to Consulting Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and Lawrence Steinman, M.D (Filed With SEC on May 27, 2022)

Second Amendment to Consulting Agreement dated April 27, 2022, between Cannbiorex Pharma Ltd. and Prof. Jagdeep Nanchahal (Filed With SEC on April 28, 2022)

First Amendment to Consulting Agreement dated April 27, 2022, between 180 Life Sciences Corp. and Lawrence Steinman, M.D (Filed With SEC on April 28, 2022)

First Amendment to Employment Agreement dated April 27, 2022, between Cannbiorex Pharma Ltd. and Sir Marc Feldmann, Ph.D (Filed With SEC on April 28, 2022)

First Amendment to Employment Agreement dated April 27, 2022, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D (Filed With SEC on April 28, 2022)

First Amendment to Employment Agreement dated April 27, 2022, between 180 Life Sciences Corp. and Quan Anh Vu (Filed With SEC on April 28, 2022)

First Amendment to Amended and Restated Employment Agreement dated April 27, 2022, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D (Filed With SEC on April 28, 2022)

Consulting Agreement dated November 17, 2021, by and between 180 Life Science Corp. and Lawrence Steinman, M.D (Filed With SEC on November 18, 2021)

Employment Agreement dated October 29, 2021, by and between 180 Life Sciences Corp. and Quan Anh Vu (Filed With SEC on November 2, 2021)

Debt Conversion Agreement dated September 30, 2021, by and between 180 Life Sciences Corp. and Dr. Lawrence Steinman and Sir Marc Feldmann (Filed With SEC on October 5, 2021)

Form of Lock-Up Agreement (August 2021 Offering) (Filed With SEC on August 24, 2021)

Registration Rights Agreement dated as of August 23, 2021 by and between 180 Life Sciences Corp. and the purchasers signatory thereto (Filed With SEC on August 24, 2021)

Engagement Letter dated August 17, 2021 between 180 Life Sciences Corp. and Maxim Group LLC (Filed With SEC on August 24, 2021)

Securities Purchase Agreement dated as of August 19, 2021 by and between 180 Life Sciences Corp. and the purchasers identified on the signature pages thereto (Filed With SEC on August 24, 2021)

Form of Purchaser Warrant (August 2021 Offering) (Filed With SEC on August 24, 2021)

Form of Stock Option Agreement (Independent Directors August 2021 Grants) (Filed With SEC on August 16, 2021)

Mutual Release and Settlement Agreement dated July 31, 2021, issued by 180 Life Sciences Corp. to Alpha Capital Anstalt (Filed With SEC on August 2, 2021)

Common Stock Purchase Warrant dated July 31, 2021, to purchase 25,000 shares of common stock of 180 Life Sciences Corp., granted to Alpha Capital Anstalt (Filed With SEC on August 2, 2021)

Dr. Lawrence Steinman Confirmation of Rescission of Note Amendments effective February 25, 2021 (Filed With SEC on July 19, 2021)

Sir Marc Feldmann Confirmation of Rescission of Note Amendments effective February 25, 2021 (Filed With SEC on July 19, 2021)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on July 9, 2021)

Second Amendment to Employment Agreement dated May 27, 2021, and effective November 6, 2020, by and between 180 Life Sciences Corp., Katexco Pharmaceuticals Corp. and Ozan Pamir (Filed With SEC on May 27, 2021)

Form of Director Nominee Offer Letter (May 2021) (Filed With SEC on May 27, 2021)

Settlement and Mutual Release Agreement dated May 4, 2021, by and between 180 Life Sciences Corp. and EarlyBirdCapital, Inc (Filed With SEC on May 7, 2021)

First Amendment to Consultancy Agreement dated March 31, 2021, by and between 180 Life Sciences Corp. and Prof Jagdeep Nanchahal (Filed With SEC on April 2, 2021)

James N. Woody - Stock Option Agreement effective February 26, 2021 (1,400,000 shares) (Filed With SEC on March 3, 2021)

Amended and Restated Employment Agreement dated February 25, 2021, and effective November 6, 2020, by and between 180 Life Sciences Corp. and James N. Woody (Filed With SEC on March 3, 2021)

Consultancy Agreement dated February 22, 2021, by and between 180 Life Sciences Corp. and Prof Jagdeep Nanchahal (Filed With SEC on March 3, 2021)

Employment Agreement dated February 24, 2021, and effective November 6, 2020, by and between 180 Life Sciences Corp. and Ozan Pamir and Amendment and Correction Thereto dated... (Filed With SEC on March 3, 2021)

Ozan Pamir - Stock Option Agreement effective February 26, 2021 (180,000 shares) (Filed With SEC on March 3, 2021)

Form of Lock-Up Agreement (Filed With SEC on February 24, 2021)

Registration Rights Agreement dated as of February 23, 2021 by and between 180 Life Sciences Corp. and the purchasers signatory thereto (Filed With SEC on February 24, 2021)

Amendment to Engagement Letter between 180 Life Sciences Corp. and Maxim Group LLC dated February 18, 2021 (Filed With SEC on February 24, 2021)

Engagement Letter dated January 26, 2021 between 180 Life Sciences Corp. and Maxim Group LLC (Filed With SEC on February 24, 2021)

Securities Purchase Agreement dated as of February 19, 2021 by and between 180 Life Sciences Corp. and the purchasers identified on the signature pages thereto (Filed With SEC on February 24, 2021)

Form of Warrant (Filed With SEC on February 24, 2021)

Amendment Agreement dated November 25, 2020 (Filed With SEC on November 27, 2020)

Escrow Agreement dated November 6, 2020 by and between the registrant, Continental Stock Transfer & Trust Company, and Lawrence Pemble (Filed With SEC on November 12, 2020)

Form of Lock-Up Agreement (Filed With SEC on November 12, 2020)

2020 Omnibus Incentive Plan (Filed With SEC on November 12, 2020)

Employment Agreement, dated July 1, 2020 by and between 180 Life Corp. (f/k/a 180 Life Sciences Corp.) and James N. Woody, M.D., Ph.D (Filed With SEC on November 12, 2020)

First Amendment to Employment Agreement by and between 180 Life Corp. (f/k/a 180 Life Sciences Corp.) and James N. Woody, M.D., Ph.D (Filed With SEC on November 12, 2020)

Convertible Promissory Note, dated September2020, issued to KBL IV Sponsor LLC (Filed With SEC on October 19, 2020)

Amended and Restated Promissory Note, dated September2020, issued to KBL IV Sponsor LLC (Filed With SEC on October 19, 2020)

Registration Rights Agreement, dated September 8, 2020, by and among the Company and the parties signatory thereto (Filed With SEC on September 14, 2020)

Securities Purchase Agreement, dated September 8, 2020, by and among the Company and the purchasers signatory thereto (Filed With SEC on September 14, 2020)

Form of 10% Senior Secured Convertible Promissory Note (Filed With SEC on September 14, 2020)

Amendment No. 2 to Business Combination Agreement, dated as of August 7, 2020, by and among KBL, the Company, Katexco, CBR Pharma, 180, Merger Sub and the Stockholder... (Filed With SEC on August 13, 2020)

Securities Purchase Agreement, dated June 12, 2020, by and among the Company and the purchasers signatory thereto (Filed With SEC on July 2, 2020)

Registration Rights Agreement, dated June 12, 2020, by and among the Company and the parties signatory thereto (Filed With SEC on July 2, 2020)

Form of 10% Senior Secured Convertible Promissory Note (Filed With SEC on July 2, 2020)

Certificate of Designations, Preferences and Rights of the Series A Convertible Preferred Stock of the Company (Filed With SEC on July 2, 2020)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 7, 2020)

Amendment No. 1 to Business Combination Agreement, dated as of January 29, 2020, by and among KBL, the Company, Katexco, CBR Pharma, 180, Merger Sub and the Stockholder... (Filed With SEC on February 3, 2020)

Promissory Note, dated August 28, 2019 issued to CannBioRx Life Sciences Corp (Filed With SEC on November 12, 2019)

Promissory Note, dated August 21, 2019 issued to CannBioRx Life Sciences Corp (Filed With SEC on November 12, 2019)

Promissory Note, dated March 15, 2019 issued to KBL IV Sponsor LLC (Filed With SEC on November 12, 2019)

Promissory Note, dated September 30, 2019 issued to CannBioRx Life Sciences Corp (Filed With SEC on November 12, 2019)

Form of Tyche Backstop Agreement (Filed With SEC on July 26, 2019)

Employment Agreement, dated as of July 23, 2019, by and between KBL and Marlene Krauss (Filed With SEC on July 26, 2019)

Form of Lock-Up Agreement, by and between KBL and certain stockholders of the Company (Filed With SEC on July 26, 2019)

Employment Agreement, dated as of July 23, 2019, by and between KBL and George Hornig (Filed With SEC on July 26, 2019)

Business Combination Agreement, dated as of July 25, 2019, by and among KBL, the Company, Katexco, CBR Pharma, 180, Merger Sub and the Stockholder Representative (Filed With SEC on July 26, 2019)

Form of Support Agreement, by and between KBL and certain stockholders of the Company (Filed With SEC on July 26, 2019)

KBL MERGER CORP. IV (86)